Rehovot, Israel – January 18, 2022 – Evogene Ltd. (NASDAQ: EVGN, TASE: EVGN), announced today it is participating in Edison Group’s Open House Event, scheduled to take place virtually this month.For more information on the event and details on how to register, please see below.

Edison Group:
Global Healthcare Open House Conference 2022
Date: January 25-27th, 2022
Event information

Presentation information: The company presentation will be available on demand on http://www.edisongroup.com beginning at 7am ET on Thursday, January 27th.  A replay of the presentation will also be available on Evogene’s investor relations page.

 1×1 Meeting Registration: To register for a 1×1 meetings with Company, please visit this link.

For any questions about the event or how to register, please reach out to lyonker@edisongroup.com.

***

About Evogene Ltd.:

Evogene (NASDAQ: EVGN, TASE: EVGN) is a leading computational biology company focused on revolutionizing product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of our broadly applicable Computational Predictive Biology (CPB) platform.  The CPB platform, incorporating a deep understanding of biology leveraged through the power of Big Data and Artificial Intelligence, has been designed to computationally discover and uniquely guide the development of life-science products based on microbes, small molecules and genetic elements.  Utilizing the CPB platform, Evogene and its subsidiaries are now advancing product pipelines for human microbiome-based therapeutics through Biomica Ltd., medical cannabis through Canonic Ltd., ag-biologicals through Lavie Bio Ltd., ag-chemicals through AgPlenus Ltd., and ag-solutions for castor oil production through Casterra Ag Ltd. For more information, please visit www.evogene.com.

 

About Edison Group:

Edison is an investment research, investor relations and consulting firm, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is its world-renowned equity research platform and deep multi-sector expertise. Edison investment research is widely read by international investors, advisors and stakeholders. Edison Advisors leverages its core research platform to provide differentiated services including investor relations and strategic consulting.

  

Contact:

Rivka Neufeld

Investor Relations and Public Relations Manager

E: IR@evogene.com

T: +972-8-931-1940

 

US Investor Relations:

Joseph Green

Edison Group

E: jgreen@edisongroup.com

T: +1 646-653-7030

Laine Yonker

Edison Group

E: lyonker@edisongroup.com

T: +1 646-653-7035

Canonic מגזין

Not Just THC: Meet the Unsung Stars of Cannabis

Not Just THC: Meet the Unsung Stars of Cannabis

If THC is the undisputed superstar of the cannabis market, then CBD is a close second. These two molecules focus most of their interest on patients, researchers and entrepreneurs alike, but cannabis has so much more to offer beyond ...

קרא עוד
At the Forefront of Technology: the Science Behind Groundbreaking Traits Cultivating

At the Forefront of Technology: the Science Behind Groundbreaking Traits Cultivating

Take a deep breath: Canonic's innovative cultivation process uses computational genomics and artificial intelligence to perform big data analyses in order to isolate and identify genetic markers that affect the phenotype of ...

קרא עוד
Introducing the Innovative Cultivation Process which Produces Higher Quality Cannabis

Introducing the Innovative Cultivation Process which Produces Higher Quality Cannabis

From the outside it appears quite routine. A small side road that winds around the lowlands and passes an agricultural farm. But what's going on inside Canonic's research and development farm is anything but routine farming: Behind the ...

קרא עוד